Process for the preparation of n-[(1s,2e)-1-cyclopropyl-3-(methanesulfonyl)prop-2-en-1-yl]-2-(1,1-difluoroethyl)-4-phenoxypyrimidine-5-carboxamide
CL202602313A1Pending Publication Date: 2026-08-21VIVIDION THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CL202602313
- Authority / Receiving Office
- CL · CL
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-01-09
- Filing Date
- 2026-07-08
- Publication Date
- 2026-08-21
Abstract
The present invention relates to a process for the preparation of compound (I), or one of its pharmaceutically acceptable salts, which is useful for the treatment of medical disorders and diseases, more especially, by the inhibition of WRN.
Need to check novelty before this filing date? Find Prior Art